Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Commentary: Per capita payments in clinical trials: reasonable costs versus bounty hunting.

Hall MA, Friedman JY, King NM, Weinfurt KP, Schulman KA, Sugarman J.

Acad Med. 2010 Oct;85(10):1554-6. doi: 10.1097/ACM.0b013e3181ef9cc6.

PMID:
20881671
2.

Bounty-hunting and finder's fees.

Christensen JA, Orlowski JP.

IRB. 2005 May-Jun;27(3):16-9. No abstract available.

PMID:
16021797
3.

NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.

Samson K.

Ann Neurol. 2010 Mar;67(3):A7-A10. doi: 10.1002/ana.22026. No abstract available.

PMID:
20373337
4.

Beyond disclosure: the necessity of trust in biomedical research.

Kahn JP.

Cleve Clin J Med. 2007 Mar;74 Suppl 2:S49-50; discussion S51-9.

PMID:
17469474
5.

Payments to children and adolescents enrolled in research: a pilot study.

Iltis AS, DeVader S, Matsuo H.

Pediatrics. 2006 Oct;118(4):1546-52.

PMID:
17015545
6.

Financial relationships of institutional review board members.

Miller FG.

N Engl J Med. 2007 Mar 1;356(9):965; author reply 965. No abstract available.

7.

Fraud, conflict of interest, and other enforcement issues in clinical research.

Sheehan JG.

Cleve Clin J Med. 2007 Mar;74 Suppl 2:S63-7; discussion S68-9.

PMID:
17471620
8.

Expedited industry-sponsored translational research: a seductive but hazardous cocktail?

Marks JH.

Am J Bioeth. 2008 Mar;8(3):56-8; discussion W1-3. doi: 10.1080/15265160802109363. No abstract available.

PMID:
18570106
9.

Industry-sponsored research.

Okike K, Kocher MS, Mehlman CT, Bhandari M.

Injury. 2008 Jun;39(6):666-80. doi: 10.1016/j.injury.2008.02.013. Review.

PMID:
18508054
10.

Potential research participants' views regarding researcher and institutional financial conflicts of interest.

Kim SY, Millard RW, Nisbet P, Cox C, Caine ED.

J Med Ethics. 2004 Feb;30(1):73-9.

11.

Oversight of financial conflicts of interest in commercially sponsored research in academic and nonacademic settings.

Weinfurt KP, Hall MA, Hardy NC, Friedman JY, Schulman KA, Sugarman J.

J Gen Intern Med. 2010 May;25(5):460-4. doi: 10.1007/s11606-010-1264-6.

12.

Prologue: a case study in biomedical conflicts.

Totenberg N.

Cleve Clin J Med. 2007 Mar;74 Suppl 2:S8-9; discussion 16-22. No abstract available.

PMID:
17471618
13.
14.

Conflicts of interest in research involving human beings.

Greco D, Diniz NM.

J Int Bioethique. 2008 Mar-Jun;19(1-2):143-54, 202-3. Review.

PMID:
18664007
15.

Intrinsic conflicts of interest in clinical research: a need for disclosure.

Sollitto S, Hoffman S, Mehlman M, Lederman RJ, Youngner SJ, Lederman MM.

Kennedy Inst Ethics J. 2003 Jun;13(2):83-91.

PMID:
14569995
16.
17.

Conflict-of-interest management: efforts and insights from the Association of American Medical Colleges.

Kirch DG.

Cleve Clin J Med. 2007 Mar;74 Suppl 2:S23-5; discussion S32-7.

PMID:
17471619
18.

Putting the "ethics" into "research ethics".

Spike J.

Am J Bioeth. 2005 Winter;5(1):51-3; author reply W15-8. No abstract available.

PMID:
16036663
19.

Patients' views on financial conflicts of interest in cancer research trials.

Hampson LA, Agrawal M, Joffe S, Gross CP, Verter J, Emanuel EJ.

N Engl J Med. 2006 Nov 30;355(22):2330-7.

20.

Uneasy alliance--clinical investigators and the pharmaceutical industry.

Bodenheimer T.

N Engl J Med. 2000 May 18;342(20):1539-44. No abstract available.

PMID:
10816196
Items per page

Supplemental Content

Support Center